Sort
30,917 grants matching “tumor microenvironment”
Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy
$344,549Alexander V Kabanov · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy
$344,549Alexander V Kabanov · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA
Project 3: The Role of Macrophages in Resistance to Anti-VEGF Drugs in Ovarian Cancer
$344,532Anil K Sood · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Use of Organotypic and Mammary Gland Models to Investigate the Outcomes of Clonal
$344,514Joan Siefert Brugge · Whitehead Institute For Biomedical Res · P01 · FY2013 · CA
Integration of stromal targeting agents with immune checkpoint therapy
$344,496Lei Zheng · Johns Hopkins University · P01 · FY2021 · CA
Integration of stromal targeting agents with immune checkpoint therapy
$344,496Lei Zheng · Johns Hopkins University · P01 · FY2025 · CA
Targeting Stat3 to Improve Immunotherapy
$344,450Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2010 · CA
Targeting Stat3 to Improve Immunotherapy
$344,450Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2009 · CA
Developing Novel Therapeutic Approaches Targeting Macrophages in GBM
$344,441Y. Alan Wang · Indiana University Indianapolis · R01 · FY2024 · CA
Project 1: EZH2 Inhibition to Prevent/Overcome Chemoresistance
$344,428Robert Page Edwards · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · CA
Molecular basis for HIV therapy-linked osteopenia
$344,400Weill Medical College Of Cornell Univ · R01 · FY2005 · DK
INITIATING THE ADAPTIVE IMMUNE RESPONSE TO CANCER
$344,323Per H. Basse · University Of Pittsburgh At Pittsburgh · P01 · FY2007 · CA
Biology Core
$344,322Meenhard Herlyn · Wistar Institute · P01 · FY2019 · CA
Stromal Cell Function Following Chemotherapy
$344,270Laura F Gibson · West Virginia University · R01 · FY2006 · HL
Roles of Hsp47 in breast cancer progression
$344,269Ren Xu · University Of Kentucky · R01 · FY2018 · CA
Roles of Hsp47 in breast cancer progression
$344,269Ren Xu · University Of Kentucky · R01 · FY2017 · CA
Roles of RORalpha in breast cancer development and progression
$344,269Ren Xu · University Of Kentucky · R01 · FY2017 · CA
Roles of Hsp47 in breast cancer progression
$344,269Ren Xu · University Of Kentucky · R01 · FY2020 · CA
Roles of RORalpha in breast cancer development and progression
$344,269Ren Xu · University Of Kentucky · R01 · FY2020 · CA
Determining the mechanisms by which calorie restriction alters macrophage polarization to promote an anti-tumor environment in epithelial ovarian cancer
$344,269Ramandeep Rattan · Henry Ford Health System · R01 · FY2021 · CA
Roles of Hsp47 in breast cancer progression
$344,269Ren Xu · University Of Kentucky · R01 · FY2021 · CA
Determining the mechanisms by which calorie restriction alters macrophage polarization to promote an anti-tumor environment in epithelial ovarian cancer
$344,269Ramandeep Rattan · Henry Ford Health System · R01 · FY2020 · CA
Endothelial PHD2/HIF Axis in Ischemic Kidney Injury and Inflammation
$344,250Pinelopi P. Kapitsinou · University Of Kansas Medical Center · R01 · FY2019 · DK
ROS and Nrf2 in arsenic carcinogenesis
$344,250Zhuo Zhang · University Of Kentucky · R01 · FY2018 · ES
Microenvironment and Arsenic Lung Tumorigenesis
$344,250Gang Chen · University Of Kentucky · R01 · FY2018 · ES